![Min-Chul Park](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Min-Chul Park
Directeur/Membre du Conseil chez
ZYVERSA THERAPEUTICS, INC.
Fortune : - $ au 31/05/2026
Profil
Min-Chul Park is the founder of Tme Therapeutics, Inc. Current positions include Director at ZyVersa Therapeutics Operating, Inc., Independent Director at ZyVersa Therapeutics, Inc. since 2022, and Assistant Professor at Inje University.
Former roles include Chief Executive Officer & Director at Neomics Co., Ltd., Chief Executive Officer & Director at Curebio Therapeutics from 2017 to 2022, Chief Executive Officer & Director at CURE BIO Co., Ltd. from 2020 to 2022, and Senior Associate-Research at Medicinal Bioconvergence Research Center.
Education includes a doctorate from Seoul National University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/07/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Min-Chul Park
| Sociétés | Poste | Début |
|---|---|---|
| ZYVERSA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/12/2022 |
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur/Membre du Conseil | - |
Inje University
 Inje University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Min-Chul Park
| Sociétés | Poste | Fin |
|---|---|---|
CURE BIO Co., Ltd.
 CURE BIO Co., Ltd. BiotechnologyHealth Technology Engages in research and development of medicines | Directeur Général | 01/04/2022 |
Neomics Co., Ltd.
 Neomics Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes diagnostics and therapeutics for human incurable diseases, such as cancer | Directeur Général | 01/01/2017 |
Medicinal Bioconvergence Research Center | Corporate Officer/Principal | - |
Formation de Min-Chul Park
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
ZyVersa Therapeutics Operating, Inc.
ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Seoul National University
 Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neomics Co., Ltd.
Neomics Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes diagnostics and therapeutics for human incurable diseases, such as cancer | Health Technology |
Inje University
Inje University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CURE BIO Co., Ltd.
CURE BIO Co., Ltd. BiotechnologyHealth Technology Engages in research and development of medicines | Health Technology |
ZyVersa Therapeutics, Inc.
 ZyVersa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops product candidates in the areas of renal and inflammatory diseases | Health Technology |
Medicinal Bioconvergence Research Center |
